PortfoliosLab logo

BioAtla, Inc. (BCAB)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS09077B1044
CUSIP09077B104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.94
Year Range$2.13 - $42.00
EMA (50)$3.63
EMA (200)$12.62
Average Volume$503.35K
Market Capitalization$147.41M

BCABShare Price Chart


Chart placeholderClick Calculate to get results

BCABPerformance

The chart shows the growth of $10,000 invested in BioAtla, Inc. in Dec 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,270 for a total return of roughly -87.30%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%MarchAprilMayJuneJulyAugust
-50.14%
-9.63%
BCAB (BioAtla, Inc.)
Benchmark (^GSPC)

BCABReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M11.93%8.19%
6M-50.93%-7.42%
YTD-79.93%-13.03%
1Y-90.08%-5.85%
5Y-71.78%7.19%
10Y-71.78%7.19%

BCABMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-51.30%-32.22%-22.84%-30.40%-30.75%18.26%19.30%15.88%
202129.29%20.76%-4.26%-2.46%-13.19%-1.56%-3.28%0.24%-28.35%-0.71%-13.62%-22.26%
20209.64%

BCABSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioAtla, Inc. Sharpe ratio is -1.01. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.50-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-1.01
-0.31
BCAB (BioAtla, Inc.)
Benchmark (^GSPC)

BCABDividend History


BioAtla, Inc. doesn't pay dividends

BCABDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-94.44%
-13.58%
BCAB (BioAtla, Inc.)
Benchmark (^GSPC)

BCABWorst Drawdowns

The table below shows the maximum drawdowns of the BioAtla, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioAtla, Inc. is 97.00%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97%Mar 19, 2021299May 24, 2022
-13.65%Feb 19, 202111Mar 5, 20212Mar 9, 202113
-9.5%Dec 18, 20205Dec 24, 20207Jan 6, 202112
-7.86%Jan 26, 20213Jan 28, 20215Feb 4, 20218
-7.65%Jan 15, 20212Jan 19, 20214Jan 25, 20216
-5.04%Feb 12, 20211Feb 12, 20212Feb 17, 20213
-3.3%Mar 15, 20211Mar 15, 20211Mar 16, 20212

BCABVolatility Chart

Current BioAtla, Inc. volatility is 71.08%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%350.00%MarchAprilMayJuneJulyAugust
71.08%
19.67%
BCAB (BioAtla, Inc.)
Benchmark (^GSPC)